Biomarin Pharmaceuticals
(BMRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,149 | -117,042 | -65,650 | -53,123 | -16,290 |
| Depreciation Amortization | 24,394 | 90,938 | 61,359 | 39,824 | 20,072 |
| Income taxes - deferred | -13,988 | 44,464 | -36,150 | -22,770 | -10,441 |
| Accounts receivable | -26,257 | -25,256 | -21,598 | -16,834 | -14,051 |
| Other Working Capital | -65,884 | -93,963 | -122,535 | -114,849 | -109,553 |
| Other Operating Activity | 83,375 | 92,102 | 161,203 | 106,089 | 49,820 |
| Operating Cash Flow | $-42,509 | $-8,757 | $-23,371 | $-61,663 | $-80,443 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -41,471 | -229,487 | -284,116 | 103,631 | 95,528 |
| PPE Investments | -30,164 | -199,219 | -159,329 | -116,847 | -69,090 |
| Purchase Sale Intangibles | N/A | 125,000 | N/A | N/A | N/A |
| Other Investing Activity | -99 | 123,247 | -1,560 | -1,560 | -1,391 |
| Investing Cash Flow | $-71,734 | $-305,459 | $-445,005 | $-14,776 | $25,047 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 481,713 | 481,713 | N/A | N/A |
| Debt Repayment | N/A | -26 | N/A | N/A | N/A |
| Common Stock Issued | 13,134 | 60,859 | 46,119 | 40,659 | 13,086 |
| Other Financing Activity | -22,899 | -35,401 | -33,783 | -28,546 | -19,829 |
| Financing Cash Flow | $-9,765 | $507,145 | $494,049 | $12,113 | $-6,743 |
| Exchange Rate Effect | -40 | -3,231 | -2,604 | 10,860 | 2,043 |
| Beginning Cash Position | 598,028 | 408,330 | 408,330 | 408,330 | 408,330 |
| End Cash Position | 473,980 | 598,028 | 431,399 | 354,864 | 348,234 |
| Net Cash Flow | $-124,048 | $189,698 | $23,069 | $-53,466 | $-60,096 |
| Free Cash Flow | |||||
| Operating Cash Flow | -42,509 | -8,757 | -23,371 | -61,663 | -80,443 |
| Capital Expenditure | -30,164 | -199,219 | -159,329 | -116,847 | -69,090 |
| Free Cash Flow | -72,673 | -207,976 | -182,700 | -178,510 | -149,533 |